We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App




Iron Supplementation Improves Hemoglobin Recovery Time Following Blood Donation

By LabMedica International staff writers
Posted on 01 Mar 2015
Print article
Image: The ADVIA Centaur XP Immunoassay System (Photo courtesy of Siemens Healthcare).
Image: The ADVIA Centaur XP Immunoassay System (Photo courtesy of Siemens Healthcare).
Among blood donors with normal hemoglobin levels, low-dose oral iron supplementation, compared with no supplementation, reduced the time to recovery of the post-donation decrease in hemoglobin.

Hemoglobin level and iron status are getting renewed attention as a donor safety issue based on increasing evidence that iron depletion is associated with fatigue, decreased exercise capacity and neurocognitive changes.

Scientists at the Institute for Transfusion Medicine (Pittsburgh, PA, USA) and their colleagues from other institutions randomly assigned 215 eligible study participants, who had not donated whole blood or red blood cells within four months to receive one tablet of ferrous gluconate daily or no iron for 24 weeks after donating a 500 mL unit of whole blood. The study was conducted at four regional blood centers in the USA.

Ferritin and soluble transferrin receptor (sTfR), were measured with the ADVIA Centaur (Siemens Healthcare Diagnostics, Deerfield, IL, USA) and a complete blood cell count (CBC) done in a pre-donation sample. Laboratory testing was performed on pre-donation EDTA blood samples collected from a sampling pouch in line with tubing used to collect the whole blood unit and then on blood samples provided on seven occasions: days 3 through 8 and at 2, 4, 8, 12, 16, and 24 weeks after donation.

The primary outcomes for the study were time to recovery of 80% of the post donation decrease in hemoglobin and recovery of ferritin level which is an indicator of the amount of total iron stored in the body. The investigators found that compared with participants who did not receive iron supplementation; those who did had shortened time to 80% hemoglobin recovery in both the low-ferritin with an average of 32 days versus 158 days, and higher-ferritin groups with an average of 31 days versus 78 days. Recovery of iron stores in all participants who received supplements took a median of 76 days; for participants not taking iron, median recovery time was longer than 168 days. Without iron supplements, 67% of participants did not recover iron stores by 168 days.

The authors concluded that although the absolute amount of hemoglobin decrease was relatively small and of marginal clinical consequence after a single blood donation, donating blood is an iterative process that leads to progressive iron loss and anemia in some frequent blood donors, so it is important that the hemoglobin decrease after blood donation be recovered before the next blood donation. Among blood donors with normal hemoglobin levels, low-dose iron supplementation, compared with no supplementation, reduced time to 80% recovery of the post donation decrease in hemoglobin concentration in donors with low ferritin (≤26 ng/mL) or higher ferritin (>26 ng/mL). The study was published on February 10, 2015, in the Journal of the American Medical Association.

Related Links:

Institute for Transfusion Medicine 
Siemens Healthcare Diagnostics 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.